DeepWise

elsewhere's corpus contains two distinct entities named "DeepWise," and the retrieved material is split between them.

**深势科技 (DeepWise / DeepPotential)** is an AI-for-Science company co-founded in 2018 by Linfeng Zhang (张林峰) and Weijie Sun (孙伟杰), who serves as CEO . The company builds computational tools for molecular simulation and materials design, aiming to partially replace lab experiments with AI-driven modeling . It has partnered with Geely Auto on a joint lab for battery safety , worked with Hengrui Medicine and other top pharmaceutical firms , and co-hosted a summit with the AI for Science Institute, Beijing . Source Code Capital led its Series B and has been a key backer, with partner Yuhao Zhang as its first investor ; Hillhouse also participated in its Series A . As of 2023, it had raised over RMB 700 million .

**深睿医疗 (Deepwise Health)** is a separate medical AI company whose products include Deepwise MetAI, a "full-process, full-scenario" intelligent radiology platform, and Deepwise TrioData, a multimodal medical data governance system . It acquired Yitu Healthcare in 2021 to add text-data capabilities to its imaging AI core , and as of early 2025 held 14 NMPA Class III certifications including the first for lung cancer AI diagnosis .

The two share only a similar romanized name and operate in entirely different sectors.